Clinical Trials Logo

Clinical Trial Summary

The present study proposes a new organization of the Day Hospital unit with several possible pathways defined by PRO. The organization realies on a platform composed of nurses supervised by an IPA and a doctor one day before a treatment in the day hospitalization unit admission, results of PROs collectyed through the CEM@santé application (a French health care application) are reviewed by nurses from the platform and chemotherapy delivery is confirmed. The study is planed in 2 steps. 1. st stage: the current circuit remains unchanged (with systematic medical or nursing validation to confirm chemotherapy administration. Patient satisfaction is collected at each visit to the day hospital unit for chemotherapy. 73 patients will be included in this phase. 2. nd stage: a short circuit is set up. If no contraindications are identified by the plateform with the remote PRO collection, patients will undergo chemotherapy directly the next day (without any medical validation. Patient satisfaction is also collected at each visit to the day hospital unit for chemotherapy. 73 patients will be included in this phase.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05552066
Study type Interventional
Source Center Eugene Marquis
Contact LAGUERRE Brigitte, Dr
Phone 02 99 25 31 82
Email b.laguerre@rennes.unicancer.fr
Status Recruiting
Phase N/A
Start date January 11, 2022
Completion date April 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT02223247 - A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors Phase 1